This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly...
This article was written by Follow Victor Dergunov is an independent investor and author with 20 years experience. He preaches diversification and shares investment...
The COVID-19 Investment Thesis May Already Be Over We previously covered Moderna (NASDAQ:MRNA) in December 2022, discussing its mixed prospects as the demand for...
Investment Thesis In last week’s article, I explained the reasons behind having included Philip Morris into The Dividend Income Accelerator Portfolio. So far, The...
Introduction I have been following Canacol Energy (TSX:CNE:CA) (OTCQX:CNNEF) for several years now, but I haven’t really been too happy with the share price...
We previously covered Lucid Group, Inc. (NASDAQ:LCID) in July 2023, discussing the stock’s dim prospects for recovery, attributed to the worsening gross margins and...
In this monthly article, we try to identify five closed-end funds (“CEFs”) that have a solid historical performance, pay high enough distributions, and offer...